View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB83 Publication ID: Spring 2023 
Title: ●Medical Marijuana and Cannabidiol Research Expansion 
Abstract:

Pursuant to Public Law 117-215, Medical Marijuana and Cannabidiol Research Expansion Act, passed on December 2, 2022, DEA plans on modifying its regulations related to the new application process and submission of supporting materials by electronic means only, through the Diversion Control Division secure online portal, for those who are manufacturing marijuana or cannabidiol for medical research and those who are conducting medical marijuana and cannabidiol research.

 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Undetermined  Unfunded Mandates: Undetermined 
CFR Citation: 21 CFR 1301   
Legal Authority: Pub. L. 117-215   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  10/00/2023 
Final Action  12/00/2023 
Additional Information: Docket Number DEA-1132
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Undetermined 
Federalism: Undetermined 
Included in the Regulatory Plan: No 
RIN Information URL: DPW@dea.gov   Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209
Email: scott.a.brinks@dea.gov